With 45 years of practiced industry experience, Dr. Klegerman works as a professor for the University of Texas and as president and chief executive officer of EchoDynamics Inc.
HOUSTON, TX, August 09, 2018 /24-7PressRelease/ -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to present Melvin Klegerman with the Albert Nelson Marquis Lifetime Achievement Award. An accomplished listee, Melvin Klegerman celebrates many years' experience in his professional network, and has been noted for achievements, leadership qualities, and the credentials and successes he has accrued in his field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
With 45 years of practiced industry experience, Dr. Klegerman works as a professor for the University of Texas and as president and chief executive officer of EchoDynamics Inc. Additionally, he is a founding member of Zymo Pharmaceuticals. Earlier in his career, he joined the University of Chicago as a research associate. Over the course of his career, Dr. Klegerman has conducted a plethora of research and honed his skills in the field through roles with Encyclopedia Britannica, Loyola University Medical Center, Michael Reese Hospital and Medical Center, the Institute of Tuberculosis Research, the University of Illinois and the Mid-Atlantic Biomedical Research Laboratory.
An expert in his field, Dr. Klegerman holds a Bachelor of Arts from the University of Illinois and a Doctor of Philosophy from Loyola University. In order to remain aware of changes in the field, he affiliates himself with the American Association for Advancement of Science, the American Heart Association and the American Society for Microbiology. Utilizing his extensive knowledge, Dr. Klegerman has served as editor of "Pharmaceutical Biotechnology: Fundamentals and Essentials" and contributed to articles in the Journal of Laboratory Clinical Medicine, the Journal of Infectious Diseases and the Journal of Thrombosis Research, among many others.
In addition to obtaining a U.S. patent for a method of Bacillus Calmette-Guerin dispersal, Dr. Klegerman has also received patents for the discovery of mycobacterial glucan anti-cancer properties and the development of echogenic liposomes for diagnosis and therapy of atherosclerosis. For his excellence in the field, he has earned numerous grants from the National Institutes of Health and the World Health Organization in addition to features in Who's Who in America, Who's Who in the Midwest and Who's Who in Medicine and Healthcare. In the coming years, Dr. Klegerman intends to continue excelling in the field as an educator and business executive.
In recognition of outstanding contributions to his profession and the Marquis Who's Who community, Melvin Klegerman has been featured on the Albert Nelson Marquis Lifetime Achievement website. Please visit www.ltachievers.com for more information about this honor.
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® now publishes many Who's Who titles, including Who's Who in America®, Who's Who in the World®, Who's Who in American Law®, Who's Who in Medicine and Healthcare®, Who's Who in Science and Engineering®, and Who's Who in Asia®. Marquis® publications may be visited at the official Marquis Who's Who® website at www.marquiswhoswho.com.
# # #